Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 45, 2015 - Issue 1
Submit an article Journal homepage
145
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Investigation on pharmacokinetics, tissue distribution and excretion of 1-triacontanol in rats by gas chromatography-tandem mass spectrometry (GC-MS/MS)

Chunfeng WangCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, People’s Republic of China and
,
Ali FanCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, People’s Republic of China and
,
Shuhua DengCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, People’s Republic of China and
,
Wenchao GaoCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, People’s Republic of China and
,
Wei ZhangCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, People’s Republic of China and
,
Wei YangCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, People’s Republic of China and
,
Xiaojie ZhuCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, People’s Republic of China and
,
Yang LuDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
&
Xijing ChenCenter of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, People’s Republic of China and Correspondence[email protected]
 show all
Pages 71-78 | Received 07 Apr 2014, Accepted 07 Jul 2014, Published online: 31 Jul 2014

References

  • Arruzazabala ML, Carbajal D, Mas R, et al. (1994). Cholesterol-lowering effects of policosanol in rabbits. Biol Res 27:205–8
  • Castaño G, Más R, Fernández JC, et al. (2000a). Efficacy and tolerability of policosanol compared with lovastatin in patients with type II hypercholesterolemia and concomitant coronary risk factors. Curr Ther Res-Clin Exp 61:137–46
  • Castaño G, Más R, Fernández L, et al. (2000b). Effects of policosanol on postmenopausal women with type II hypercholesterolemia. Gynecol Endocrinol 13:1–9
  • Castaño G, Más R, Fernández JC, et al. (2001). Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk. J Gerentol 56:M186–92
  • Castaño G, Mas R, Fernández L, et al. (2003). Comparison of the efficacy and tolerability of policosanol and atorvastatin in elderly patients with type II hypercholesterolemia. Drug Aging 20:153–63
  • Dullens SP, Mensink RP, Bragt MC (2008). Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice. J Lipid Res 49:790–6
  • Fan XE, Zhang RW, Cheng HJ. (2011). Use of triacontanol in preparation of medicaments for treatment of cancers. U.S. Patent No. 7863337B2
  • Haim D, Berríos M, Valenzuela A, Videla LA (2009). Trace quantification of 1-octacosanol and TA and their main metabolites in plasma by liquid-liquid extraction coupled with gas chromatography-mass spectrometry. J Chromatogr B 877:4154–8
  • Hernández J, Illnait J, Más R, et al. (1992). Effects of policosanol on serum lipids and lipoproteins in healthy volunteers. Curr Ther Res-Clin Exp 51:568–75
  • Más R (2000). Policosanol-hypolipidemic antioxidant treatment of atherosclerosis. Drug Future 25:569–86
  • Más R, Castaño G, Fernández L, et al. (2001). Effects of policosanol in older hypercholesterolemic patients with coronary disease. Clin Drug Invest 21:485–97
  • Más R, Castaño G, Illnait J, et al. (1998). Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther 65:439–47
  • Menendez R, Amor AM, Gonzalez RM, et al. (1996). Effect of policosanol on the hepatic cholesterol biosynthesis of normocholes-terolemic beagles. Biol Res 29:253–7
  • Mesa AR, Más R, Noa M, et al. (1994). Toxicity of policosanol in beagles dogs: one-year study. Toxicol Lett 73:81–90
  • Noa M, Más R, de la Rosa MC, Magraner J (1995). Effect of policosanol on lipofundin-induced atherosclerotic lesions in beagles. J Pharm Pharmacol 47:289–91
  • Pons P, Rodríguez M, Robaina C, et al. (1994). Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment. Int J Clin Pharmacol Res 14:27–33
  • Rodríguez-Echenique C, Mesa R, Más R, et al. (1994). Effects of policosanol chronically administered in male monkeys (Macaca arctoides). Food Chem Toxicol 32:565–75
  • Zhang RW, Cheng HJ, Fan XE. (2008). The application of 1-triacontanol in the preparation of anti-cancer drugs. China Patent No. 101190210A

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.